NYSE:MDT • IE00BTN1Y115
The current stock price of MDT is 99.49 USD. In the past month the price increased by 0.49%. In the past year, price increased by 7.2%.
ChartMill assigns a technical rating of 5 / 10 to MDT. When comparing the yearly performance of all stocks, MDT turns out to be only a medium performer in the overall market: it outperformed 55.49% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to MDT. MDT has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months MDT reported a non-GAAP Earnings per Share(EPS) of 5.63. The EPS increased by 7.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.71% | ||
| ROA | 5.22% | ||
| ROE | 9.79% | ||
| Debt/Equity | 0.57 |
35 analysts have analysed MDT and the average price target is 112.06 USD. This implies a price increase of 12.64% is expected in the next year compared to the current price of 99.49.
For the next year, analysts expect an EPS growth of 3.73% and a revenue growth 7.62% for MDT
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.62 | 195.936B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.53 | 172.536B | ||
| SYK | STRYKER CORP | 24.21 | 139.985B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.34 | 110.826B | ||
| IDXX | IDEXX LABORATORIES INC | 42.48 | 50.254B | ||
| BDX | BECTON DICKINSON AND CO | 11.16 | 50.113B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.52 | 44.027B | ||
| RMD | RESMED INC | 20.57 | 36.792B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16 | 36.615B | ||
| DXCM | DEXCOM INC | 27.73 | 27.309B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Galway, Connacht and currently employs 95,000 full-time employees. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
MEDTRONIC PLC
Building Two Parkmore Business Park West
GALWAY CONNACHT D02 IE
CEO: Geoffrey S. Martha
Employees: 95000
Phone: 35314381700
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Galway, Connacht and currently employs 95,000 full-time employees. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
The current stock price of MDT is 99.49 USD. The price decreased by -1.38% in the last trading session.
MEDTRONIC PLC (MDT) has a dividend yield of 2.82%. The yearly dividend amount is currently 2.77.
MDT has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
35 analysts have analysed MDT and the average price target is 112.06 USD. This implies a price increase of 12.64% is expected in the next year compared to the current price of 99.49.
MEDTRONIC PLC (MDT) will report earnings on 2026-02-17, before the market open.
The outstanding short interest for MEDTRONIC PLC (MDT) is 1.31% of its float.